A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

~51 mi. (McAllen, Texas, +173 more cities)

Vannie Cook Children's Clinic

B-Cell Lymphoblastic Leukemia/Lymphoma

asparaginase Erwinia chrysanthemi, +12 more drugs

chemotherapy, +2 more types

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

~51 mi. (McAllen, Texas, +280 more cities)

MorphoSys Research Site

ALK Fusion, +4 more biomarkers

ALK-Positive Large B-Cell Lymphoma, +7 more conditions

cyclophosphamide, +6 more drugs

chemotherapy, +3 more types

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

~51 mi. (McAllen, Texas, +171 more cities)

Vannie Cook Children's Clinic

B-Cell Acute Lymphoblastic Leukemia, +2 more conditions

calaspargase pegol, +13 more drugs

chemotherapy, +2 more types

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

~51 mi. (McAllen, Texas, +822 more cities)

Texas Oncology-McAllen

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

carboplatin, +3 more drugs

chemotherapy

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

~51 mi. (McAllen, Texas, +160 more cities)

USOR: Texas Oncology - McAllen South Second

FOLR1 Expression

Fallopian Tube Carcinoma, +2 more conditions

mirvetuximab soravtansine

chemotherapy, +1 more type

Study of Sacituzumab Govitecan-hziy (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-programmed Death Protein 1 (PD-1)/Programmed Death Ligand 1 (PD-L1) Immunotherapy

~51 mi. (McAllen, Texas, +17 more cities)

Texas Oncology Cancer Care and Research Center

Non-Small Cell Lung Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer

~51 mi. (McAllen, Texas, +186 more cities)

Texas Oncology, P.A. - McAllen; South Texas Cancer Center-McAllen

ER Positive, +3 more biomarkers

Breast Carcinoma

fulvestrant, +2 more drugs

hormone therapy, +1 more type

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

~51 mi. (McAllen, Texas, +79 more cities)

Texas Oncology - McAllen

Mantle Cell Lymphoma

pirtobrutinib

targeted therapy

Project: Every Child for Younger Patients With Cancer

~51 mi. (McAllen, Texas, +185 more cities)

Vannie Cook Children's Clinic

Carcinoma In Situ, +8 more conditions

observation

Other

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

~51 mi. (McAllen, Texas, +13 more cities)

Texas Oncology, P.A. (McAllen)

Pancreatic Carcinoma

CBP501, +2 more drugs

chemotherapy, +2 more types

A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation

~51 mi. (McAllen, Texas, +50 more cities)

South Texas Cancer Center - McAllen

Chronic Lymphocytic Leukemia

obinutuzumab, +1 more drug

chemotherapy, +1 more type

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With CLL or SLL

~51 mi. (McAllen, Texas, +71 more cities)

Texas Oncology - McAllen

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

pirtobrutinib

targeted therapy